CV Sciences (CVSI) Gains from Investment Securities (2016 - 2025)
CV Sciences (CVSI) has disclosed Gains from Investment Securities for 13 consecutive years, with $130000.0 as the latest value for Q2 2025.
- Quarterly Gains from Investment Securities fell 99.52% to $130000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $45000.0 through Dec 2025, down 2.17% year-over-year, with the annual reading at $39.9 million for FY2025, 48.91% up from the prior year.
- Gains from Investment Securities hit $130000.0 in Q2 2025 for CV Sciences, up from $30000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $26.8 million in Q2 2024 to a low of -$495000.0 in Q4 2022.
- Historically, Gains from Investment Securities has averaged $2.2 million across 5 years, with a median of $5000.0 in 2021.
- Biggest five-year swings in Gains from Investment Securities: tumbled 1446.88% in 2022 and later skyrocketed 2684700.0% in 2024.
- Year by year, Gains from Investment Securities stood at -$32000.0 in 2021, then crashed by 1446.88% to -$495000.0 in 2022, then skyrocketed by 99.19% to -$4000.0 in 2023, then soared by 1325.0% to $49000.0 in 2024, then soared by 165.31% to $130000.0 in 2025.
- Business Quant data shows Gains from Investment Securities for CVSI at $130000.0 in Q2 2025, $30000.0 in Q1 2025, and $49000.0 in Q4 2024.